Eli Lilly's Zepbound sales, Pfizer wants in on weight loss drugs, AbbVie's big deal: Pharma news round up
qz.com › eli-lilly-zepbound-sales-pfizer-weight-loss-drugs-1851686815
This story seems to be about:
This story seems to be about:
Eli Lilly CEO David Ricks told investors this week that the sale of cheaper, knockoff versions of the company’s blockbuster weight loss drug Zepbound was not dragging down sales. Pfizer sales rose 31% to $17.7 billion in the third quarter of 2024, driven by a surge in demand for the pharma giant’s COVID-19 medications.…